Cleared Special

K071681 - CYTOMICS FC 500 MPL FLOW CYTOMETER

K071681 is the FDA 510(k) clearance for CYTOMICS FC 500 MPL FLOW CYTOMETER by Beckman Coulter, Inc.. It is a Class 2 Hematology device (product code GKZ) cleared through the Special 510(k) pathway after a 107-day FDA review.

K071681 · Beckman Coulter, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2007
Decision
107d
Days
Class 2
Risk

K071681 is an FDA 510(k) clearance for the CYTOMICS FC 500 MPL FLOW CYTOMETER, MODEL # 626554. Classified as Counter, Differential Cell (product code GKZ), Class II - Special Controls.

Submitted by Beckman Coulter, Inc. (Miami, US). The FDA issued a Cleared decision on October 4, 2007 after a review of 107 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Beckman Coulter, Inc. devices

Submission Details

510(k) Number K071681 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 19, 2007
Decision Date October 04, 2007
Days to Decision 107 days
Submission Type Special
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
6d faster than avg
Panel avg: 113d · This submission: 107d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code GKZ Counter, Differential Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKZ Counter, Differential Cell

All 193
Devices cleared under the same product code (GKZ) and FDA review panel - the closest regulatory comparables to K071681.
CELL-DYN EMERALD SYSTEM
K081495 · Abbott Laboratories · Feb 2009
UNICEL DXH 800 COULTER CELLULAR ANALYSIS SYSTEM
K081930 · Beckman Coulter, Inc. · Dec 2008
FLOWCARE TLG REAGENT
K081526 · Beckman Coulter, Inc. · Aug 2008
BC-3200 AUTO HEMATOLOGY ANALYZER
K063407 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Jun 2007
COULTER LH 780 HEMATOLOGY ANALYZER
K061616 · Beckman Coulter, Inc. · Oct 2006
COULTER LH 750 HEMATOLOGY ANALYZER, MODEL 6605632
K061574 · Beckman Coulter, Inc. · Jul 2006